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HIV and Injection Drug Use 
 Syringe Services Programs for HIV Prevention 
Sharing needles, syringes, and other injection equipment 
puts people who inject drugs (PWID) at high risk for getting 
HIV and other infections, including hepatitis. Annual HIV 
diagnoses among black and Hispanic/Latino PWID were cut in 
half between 2008–2014, but diagnoses among white PWID 
dropped by only 28%. One reason may be that fewer blacks 
and Hispanics/Latinos are sharing needles and syringes, 
while whites are more likely to share them. Syringe services 
programs (SSPs) can play a role in preventing HIV and other 
health problems among PWID. They provide access to sterile 
syringes and should also provide comprehensive services such 
as help with stopping substance misuse; testing and linkage 
to treatment for HIV, hepatitis B, and hepatitis C; education on 
what to do for an overdose; and other prevention services. State 
and local health departments can work with their lawmakers 
and law enforcement to make SSPs more available to PWID.
State and local health departments can:
 ■ Use data on HIV, hepatitis, substance use, and overdoses to 
determine where services are needed.
 ■ Work with law enforcement and local leaders to expand access 
to SSPs, where permitted by law.
 ■ Provide HIV and hepatitis testing and prevention services for PWID. 
 ■ Ensure treatment is available for overdoses, HIV, hepatitis, 
and substance use disorder, and inform first responders about 
available resources.
1 in 10
1 in 10 HIV diagnoses 
are among people 
who inject drugs 
(PWID).
50%
More than half of 




Only 1 in 4 PWID 
got all their syringes 
from sterile sources 
in 2015.
Want to learn more? www.cdc.gov/vitalsigns/hiv-drug-use
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The number of PWID getting HIV has been cut in  
half in the U.S. 
 ■ Annual HIV diagnoses among PWID decreased by 48% 
overall (2008–2014). 
 ■ Annual HIV diagnoses fell by about 50% among black and 
Hispanic/Latino PWID, both in urban and nonurban areas 
(2008–2014). 
 ■ Annual HIV diagnoses dropped by 28% among urban white 
PWID during 2008–2012, but did not decrease from 2012–
2014. Trends among nonurban whites were similar.
There have been changes in who is starting to inject drugs.*
 ■ In 2005, blacks and whites each made up 38% of new  
PWID (those who have been injecting for 5 years or less).
HIV diagnoses among PWID have 
decreased, but progress has been uneven. 
*In 22 cities with a high number of HIV cases 

















SOURCE: CDC’s National HIV Behavioral Surveillance data, 2005-2015
SOURCE: National Survey on Drug 
Use and Health, 2002-2013
Heroin use has increased 
more than 60% 
(114% in whites) in 
recent years. The heroin 
and prescription opioid 
epidemics could lead 
to new HIV outbreaks.
60%Percent of new PWID by race suggests fewer blacks, and more whites, 
are starting to inject drugs
 ■ In 2015, blacks made up 19% of new PWID and whites 
made up 54%. 
 ■ The percent of new PWID who are Hispanic/Latino stayed 
around the same at about 21%.
Some PWID are at higher risk for getting HIV from 
sharing syringes.* 
 ■ About 46% of new white PWID shared syringes, compared 
with 32% of Hispanics/Latinos and 28% of blacks.
 ■ White PWID started injecting at younger ages than other 
races/ethnicities, and younger people were more likely to 
share syringes.
 ■ Syringe sharing was low (13%) among PWID who got all 
their syringes from sterile sources like SSPs, but high (41%) 
among those who didn’t. 
Problem:
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A community-based program 
that ideally provides comprehensive servicesWhat is an SSP?
HIV diagnoses are down among PWID. 
More access to SSPs could help reduce HIV further.
SSPs DON’T increase illegal drug use or crime 
but DO reduce HIV risk.
Syringe services programs: http://bit.ly/2dhkAsq       Find an SSP: http://bit.ly/2dhktgB 
Referral to substance use 
disorder treatment, including 
medication-assisted treatment
HIV and hepatitis testing 
and linkage to treatment
Safe disposal of 
needles and syringes
Free sterile needles 
and syringes




Other tools to prevent 
HIV and hepatitis, 
including counseling, 
condoms, and PrEP 
(a medicine to 
prevent HIV)
Hepatitis A and B 
vaccination
Syringe Services Programs: More than Just Needle Exchange
What Can Be Done?
The Federal government is
 ■ Allowing certain state and local prevention programs 
to use their federal funds for SSPs (not to buy 
needles, syringes, and other injection equipment). 
For more information, visit http://bit.ly/2eVU8ab.
 ■ Providing support and access to HIV, hepatitis, and 
substance use disorder prevention and treatment, 
including medication-assisted treatment and mental 
health services. 
 ■ Providing guidelines to healthcare providers for 
appropriate prescribing practices to reduce opioid 
abuse and overdoses.
 ■ Monitoring national trends for HIV, hepatitis, and 
drug overdoses.
State and local health departments can 
 ■ Use data on HIV, hepatitis, substance use, and 
overdoses to determine where services are needed. 
 ■ Work with law enforcement and local leaders to 
expand access to SSPs, where permitted by law.
 ■ Provide HIV and hepatitis testing and prevention 
services for PWID.
 ■ Ensure treatment is available for overdoses, HIV, 
hepatitis, and substance use disorder, and inform 
first responders about available resources.
Healthcare providers can
 ■ Screen patients for substance use disorder, including 
the misuse of prescription opioids. Provide or link 
PWID to medication-assisted treatment, and link 
them to mental health services, if needed. Use CDC 
opioid prescribing guidelines, http://bit.ly/1jTLLej.
 ■ Test PWID for HIV and hepatitis and treat them if 
they are infected. Vaccinate patients for hepatitis A 
and B, if appropriate.
 ■ Prescribe sterile syringes to PWID, or refer them to 
SSPs or pharmacies that provide sterile syringes, 
where permitted by law.
 ■ Provide or refer PWID to HIV risk reduction 
counseling. Consider prescribing pre-exposure 
prophylaxis (PrEP) for PWID at very high HIV risk.
 ■ Prevent overdose deaths by providing naloxone or 
referring PWID to pharmacies or community-based 
programs that provide it, where permitted by law. 
Lawmakers, judges, police and other 
criminal justice officials can
 ■ Address legal and law enforcement barriers 
that prevent or discourage the use of SSPs and 
substance use disorder treatment, including use  
of medication-assisted treatment.
 ■ Refer PWID to substance use disorder treatment  
and HIV and hepatitis prevention services.
 ■ Support HIV and hepatitis testing and care and 
hepatitis vaccination in prisons and jails.
People who inject drugs can
 ■ Get help to stop injecting drugs. SAMHSA.gov,  
or 1-800-662-HELP (4357). 
 ■ Use only new, sterile syringes, safely dispose of 
used syringes, and never share any equipment if 
injecting drugs. Contact the local health department 
or NASEN.org to find an SSP.
 ■ Get tested for HIV and hepatitis C at least once a 
year. Get vaccinated for hepatitis A and B if not 
infected. People who have HIV or hepatitis should 
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